Belantamab mafodotin (belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study update.

Correspondence to Dr Ada Tang, School of Rehabilitation Sciences, McMaster University Faculty of Health Sciences, Hamilton, Canada; atang{at}mcmaster.ca Objective To determine the superiority of ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

A new UCLA study reveals that a widely used federal hospital safety metric is fundamentally flawed when applied to emergency stroke care, potentially creating incentives that may discourage hospitals ...

COLUMBUS, Ohio--(BUSINESS WIRE)--Basking Biosciences, a clinical-stage biopharmaceutical company developing the first reversible thrombolytic therapeutic for ischemic stroke, today announced the ...

According to Lin, whose research focuses on stroke recovery and rehabilitation, previous studies at UAB, like the REGARDS study, have looked at disparities regarding stroke care. This prompted him and ...